MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ELV made $50,181M in revenue. $1,764M in net income. Net profit margin of 3.52%.

Income Overview

Revenue
$50,181M
Net Income
$1,764M
Net Profit Margin
3.52%
EPS
$8
Unit: Million (M) dollars
Revenue Breakdown
    • Health Benefits Segment-Operatin...
    • Product and service revenue-Prod...
    • Health Benefits Segment
    • Others
Revenue Breakdown
    • Health Benefits Segment-Operatin...
    • Carelon Rx Segment
    • Carelon Services Segment
    • Others

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenues
50,181 49,747 50,711 49,776
Benefit expense
35,615 38,065 38,140 36,706
Cost of products sold
5,463 5,522 5,380 5,293
Operating expense
6,330 5,415 5,272 4,997
Interest expense
357 366 351 341
Amortization of other intangible assets
112 164 162 147
Total expenses
47,877 49,532 49,305 47,484
Income before income tax expense
2,304 215 1,406 2,292
Income tax expense
544 -331 219 548
Net income
1,760 546 1,187 1,744
Net loss attributable to noncontrolling interests
-4 -1 -2 1
Shareholders net income
1,764 547 1,189 1,743
Basic EPS
8.03 2.474 5.32 7.74
Diluted EPS
8 2.467 5.32 7.72
Basic Average Shares
219,800,000 221,100,000 223,300,000 225,200,000
Diluted Average Shares
220,400,000 221,700,000 223,700,000 225,800,000
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Premiums Earned Net$779M (-48.07%↓ Y/Y)Carelon ServicesSegment$203M (-8.97%↓ Y/Y)Carelon Rx Segment$4M (33.33%↑ Y/Y)Health BenefitsSegment-Operating Segments$40,452M (2.18%↑ Y/Y)Operating Segments-TotalCarelon$779M (-48.07%↓ Y/Y)Health BenefitsSegment$2,038M (10.58%↑ Y/Y)Total Carelon$207M (-8.41%↓ Y/Y)Premiums$41,024M (0.34%↑ Y/Y)Product and servicerevenue-Product$6,225M (7.16%↑ Y/Y)Product and servicerevenue-Service Fees$2,245M (8.51%↑ Y/Y)Intersegment Elimination-$207M (-2.99%↓ Y/Y)Total operatingrevenue$49,494M (1.49%↑ Y/Y)Net investmentincome$765M (29.66%↑ Y/Y)Total revenues$50,181M (2.64%↑ Y/Y)Net losses onfinancial instruments-$78M (83.19%↑ Y/Y)Income before incometax expense$2,304M (-17.63%↓ Y/Y)Total expenses$47,877M (3.87%↑ Y/Y)Net income$1,760M (-19.41%↓ Y/Y)Net lossattributable to...-$4M (-500.00%↓ Y/Y)Income tax expense$544M (-11.26%↓ Y/Y)Benefit expense$35,615M (0.86%↑ Y/Y)Operating expense$6,330M (19.43%↑ Y/Y)Cost of products sold$5,463M (9.63%↑ Y/Y)Interest expense$357M (3.78%↑ Y/Y)Amortization of otherintangible assets$112M (-27.74%↓ Y/Y)Shareholders net income$1,764M (-19.19%↓ Y/Y)

Apex-Header-svg

Elevance Health, Inc. (ELV)

Apex-Header-svg

Elevance Health, Inc. (ELV)